Screening for ovarian cancer.
Ovarian cancer is the leading cause of death from gynaecological malignancies. No precancerous lesions have been identified. Bimanual examination has not been proven to be of value as a screening test. Transvaginal ultrasound examination, with or without measurement of CA 125 levels, is currently being evaluated for population screening. Women at high risk of ovarian cancer should be screened annually - with measurement of CA 125 level and transvaginal ultrasound examination.
Anderiesz
Cleola
C
National Cancer Control Initiative, Carlton, VIC, Australia.
Quinn
Michael A
MA
D015415:Biomarkers / Q000032:analysis; D018394:CA-125 Antigen / Q000032:analysis; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D010051:Ovarian Neoplasms / Q000517:prevention & control*; D010053:Ovary / Q000000981:diagnostic imaging; D011237:Predictive Value of Tests; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014463:Ultrasonography
D015415:Biomarkers; D018394:CA-125 Antigen